Global Artificial Pancreas Closed Loop System Market Research Report 2024

Publication ID:

PB508249678

Publication Date:

August 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Artificial Pancreas Closed Loop System is an automatic insulin delivery device (AID), which can automatically infuse basal insulin to make our blood sugar more stable at night. Although insulin needs to be infused manually during meals, its operation interface will provide intelligent Mealtime insulin dosage recommendations.
The global Artificial Pancreas Closed Loop System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Pancreas Closed Loop System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Pancreas Closed Loop System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artificial Pancreas Closed Loop System include Johnson & Johnson, Medtronic, JDRF, Tandem Diabetes Care, Pancreum, TypeZero Technologies, Beta Bionics, Insulet Corp and Bigfoot Biomedical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Closed Loop System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Closed Loop System.
Report Scope
The Artificial Pancreas Closed Loop System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Pancreas Closed Loop System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Pancreas Closed Loop System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Medtronic
JDRF
Tandem Diabetes Care
Pancreum
TypeZero Technologies
Beta Bionics
Insulet Corp
Bigfoot Biomedical
Dexcom
Segment by Type
Commercial Closed Loop System
DIY Closed Loop System
Segment by Application
Hospital
Clinic
Family
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Pancreas Closed Loop System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Pancreas Closed Loop System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Artificial Pancreas Closed Loop System Market Overview
1.1 Product Overview and Scope of Artificial Pancreas Closed Loop System
1.2 Artificial Pancreas Closed Loop System Segment by Type
1.2.1 Global Artificial Pancreas Closed Loop System Market Value Comparison by Type (2024-2030)
1.2.2 Commercial Closed Loop System
1.2.3 DIY Closed Loop System
1.3 Artificial Pancreas Closed Loop System Segment by Application
1.3.1 Global Artificial Pancreas Closed Loop System Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Family
1.4 Global Artificial Pancreas Closed Loop System Market Size Estimates and Forecasts
1.4.1 Global Artificial Pancreas Closed Loop System Revenue 2019-2030
1.4.2 Global Artificial Pancreas Closed Loop System Sales 2019-2030
1.4.3 Global Artificial Pancreas Closed Loop System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Pancreas Closed Loop System Market Competition by Manufacturers
2.1 Global Artificial Pancreas Closed Loop System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Pancreas Closed Loop System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Pancreas Closed Loop System Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Pancreas Closed Loop System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Pancreas Closed Loop System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Pancreas Closed Loop System, Product Type & Application
2.7 Artificial Pancreas Closed Loop System Market Competitive Situation and Trends
2.7.1 Artificial Pancreas Closed Loop System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Pancreas Closed Loop System Players Market Share by Revenue
2.7.3 Global Artificial Pancreas Closed Loop System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Pancreas Closed Loop System Retrospective Market Scenario by Region
3.1 Global Artificial Pancreas Closed Loop System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Pancreas Closed Loop System Global Artificial Pancreas Closed Loop System Sales by Region: 2019-2030
3.2.1 Global Artificial Pancreas Closed Loop System Sales by Region: 2019-2024
3.2.2 Global Artificial Pancreas Closed Loop System Sales by Region: 2025-2030
3.3 Global Artificial Pancreas Closed Loop System Global Artificial Pancreas Closed Loop System Revenue by Region: 2019-2030
3.3.1 Global Artificial Pancreas Closed Loop System Revenue by Region: 2019-2024
3.3.2 Global Artificial Pancreas Closed Loop System Revenue by Region: 2025-2030
3.4 North America Artificial Pancreas Closed Loop System Market Facts & Figures by Country
3.4.1 North America Artificial Pancreas Closed Loop System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Pancreas Closed Loop System Sales by Country (2019-2030)
3.4.3 North America Artificial Pancreas Closed Loop System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artificial Pancreas Closed Loop System Market Facts & Figures by Country
3.5.1 Europe Artificial Pancreas Closed Loop System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Pancreas Closed Loop System Sales by Country (2019-2030)
3.5.3 Europe Artificial Pancreas Closed Loop System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Pancreas Closed Loop System Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Pancreas Closed Loop System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Pancreas Closed Loop System Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Pancreas Closed Loop System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Artificial Pancreas Closed Loop System Market Facts & Figures by Country
3.7.1 Latin America Artificial Pancreas Closed Loop System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Pancreas Closed Loop System Sales by Country (2019-2030)
3.7.3 Latin America Artificial Pancreas Closed Loop System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Pancreas Closed Loop System Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Pancreas Closed Loop System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Pancreas Closed Loop System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Pancreas Closed Loop System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Pancreas Closed Loop System Sales by Type (2019-2030)
4.1.1 Global Artificial Pancreas Closed Loop System Sales by Type (2019-2024)
4.1.2 Global Artificial Pancreas Closed Loop System Sales by Type (2025-2030)
4.1.3 Global Artificial Pancreas Closed Loop System Sales Market Share by Type (2019-2030)
4.2 Global Artificial Pancreas Closed Loop System Revenue by Type (2019-2030)
4.2.1 Global Artificial Pancreas Closed Loop System Revenue by Type (2019-2024)
4.2.2 Global Artificial Pancreas Closed Loop System Revenue by Type (2025-2030)
4.2.3 Global Artificial Pancreas Closed Loop System Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Pancreas Closed Loop System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Pancreas Closed Loop System Sales by Application (2019-2030)
5.1.1 Global Artificial Pancreas Closed Loop System Sales by Application (2019-2024)
5.1.2 Global Artificial Pancreas Closed Loop System Sales by Application (2025-2030)
5.1.3 Global Artificial Pancreas Closed Loop System Sales Market Share by Application (2019-2030)
5.2 Global Artificial Pancreas Closed Loop System Revenue by Application (2019-2030)
5.2.1 Global Artificial Pancreas Closed Loop System Revenue by Application (2019-2024)
5.2.2 Global Artificial Pancreas Closed Loop System Revenue by Application (2025-2030)
5.2.3 Global Artificial Pancreas Closed Loop System Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Pancreas Closed Loop System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Artificial Pancreas Closed Loop System Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Artificial Pancreas Closed Loop System Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 JDRF
6.3.1 JDRF Corporation Information
6.3.2 JDRF Description and Business Overview
6.3.3 JDRF Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 JDRF Artificial Pancreas Closed Loop System Product Portfolio
6.3.5 JDRF Recent Developments/Updates
6.4 Tandem Diabetes Care
6.4.1 Tandem Diabetes Care Corporation Information
6.4.2 Tandem Diabetes Care Description and Business Overview
6.4.3 Tandem Diabetes Care Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tandem Diabetes Care Artificial Pancreas Closed Loop System Product Portfolio
6.4.5 Tandem Diabetes Care Recent Developments/Updates
6.5 Pancreum
6.5.1 Pancreum Corporation Information
6.5.2 Pancreum Description and Business Overview
6.5.3 Pancreum Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pancreum Artificial Pancreas Closed Loop System Product Portfolio
6.5.5 Pancreum Recent Developments/Updates
6.6 TypeZero Technologies
6.6.1 TypeZero Technologies Corporation Information
6.6.2 TypeZero Technologies Description and Business Overview
6.6.3 TypeZero Technologies Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TypeZero Technologies Artificial Pancreas Closed Loop System Product Portfolio
6.6.5 TypeZero Technologies Recent Developments/Updates
6.7 Beta Bionics
6.6.1 Beta Bionics Corporation Information
6.6.2 Beta Bionics Description and Business Overview
6.6.3 Beta Bionics Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beta Bionics Artificial Pancreas Closed Loop System Product Portfolio
6.7.5 Beta Bionics Recent Developments/Updates
6.8 Insulet Corp
6.8.1 Insulet Corp Corporation Information
6.8.2 Insulet Corp Description and Business Overview
6.8.3 Insulet Corp Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Insulet Corp Artificial Pancreas Closed Loop System Product Portfolio
6.8.5 Insulet Corp Recent Developments/Updates
6.9 Bigfoot Biomedical
6.9.1 Bigfoot Biomedical Corporation Information
6.9.2 Bigfoot Biomedical Description and Business Overview
6.9.3 Bigfoot Biomedical Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bigfoot Biomedical Artificial Pancreas Closed Loop System Product Portfolio
6.9.5 Bigfoot Biomedical Recent Developments/Updates
6.10 Dexcom
6.10.1 Dexcom Corporation Information
6.10.2 Dexcom Description and Business Overview
6.10.3 Dexcom Artificial Pancreas Closed Loop System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dexcom Artificial Pancreas Closed Loop System Product Portfolio
6.10.5 Dexcom Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Pancreas Closed Loop System Industry Chain Analysis
7.2 Artificial Pancreas Closed Loop System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Pancreas Closed Loop System Production Mode & Process
7.4 Artificial Pancreas Closed Loop System Sales and Marketing
7.4.1 Artificial Pancreas Closed Loop System Sales Channels
7.4.2 Artificial Pancreas Closed Loop System Distributors
7.5 Artificial Pancreas Closed Loop System Customers
8 Artificial Pancreas Closed Loop System Market Dynamics
8.1 Artificial Pancreas Closed Loop System Industry Trends
8.2 Artificial Pancreas Closed Loop System Market Drivers
8.3 Artificial Pancreas Closed Loop System Market Challenges
8.4 Artificial Pancreas Closed Loop System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Johnson & Johnson
Medtronic
JDRF
Tandem Diabetes Care
Pancreum
TypeZero Technologies
Beta Bionics
Insulet Corp
Bigfoot Biomedical
Dexcom

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂